CMAC is a world-class international hub for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future.

Find out more

Our Vision

CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made.  The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Roche and Takeda.  Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 45 PhD students, as well as an experienced support team.


  • conducts world class resarch in continuous manufacturing and advanced crystallisation;
  • conducts fundamental research;
  • develops new solutions to company specific problems;
  • delivers measurable successes that are of real benefit to society;
  • creates commercial opportunities for start-ups and major global companies;
  • produces a talent pipeline of highly skilled multi-disciplinary staff;
  • influences policy, government, and regulators;
  • understands and integrates with the broader supply chain context
  • collaborates with world class business and academia on an international basis.


Industrially relevant research delivered by a multidisciplinary and collaborative academic team

Find out more
Award Winning Facility

Comprehensive suite of continuous processing, process analysis, and characterisation equipment housed in the Technology and Innovation Centre at Strathclyde

Find out more
Training & Skills

A vibrant world-class, multi-disciplinary PhD & MSc training programmes that will equip graduates with leading edge skills in pioneering continuous processes

Find out more
Translation to Industry

The demand-led manufacturing research scope of the Centre was co-created with our industry partners

Find out more


Our Partners


Press: Article in Pharmaceutical Online
CMAC’s John Mulgrew has published an article in Pharmaceutical Online about the REMEDIES project and CMAC’s contribution to it. .... more

Prof Litster wins Geldart Medal from IChemE
CMAC’s Prof Jim Litster (Sheffield) has won the Geldart Medal from IChemE.

The medal founded in 2014, is awarded biennially to one or more individuals who have made a significant recent contribution to research in particle technology. This is recognised through scientific advancements widely acknowledged within the community and high impact findings recognised outside the particle technology community.

.... more

CMAC in Chemistry World
CMAC has featured in the April 3rd edition of Chemistry World. The article "The Flow Revolution" can be read here though you will need a subscription to RSC in order to access it..... more